News from boston scientific A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 31, 2013, 17:40 ET

Boston Scientific Lotus™ Valve System Meets Primary Performance Endpoint In REPRISE II Trial

 The Boston Scientific Corporation (NYSE: BSX) Lotus™ Valve System met a key performance measure in the treatment of symptomatic...

Oct 31, 2013, 09:00 ET

Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2013 Credit Suisse Healthcare Conference on November 12 in Scottsdale,...

Oct 28, 2013, 21:48 ET

New Data Continue to Show Significant and Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

Patients treated with the Boston Scientific (NYSE: BSX) Vessix™ Renal Denervation System experienced a significant and sustained reduction in...

Oct 28, 2013, 10:02 ET

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

 Boston Scientific Corporation (NYSE: BSX) will highlight the strength of its advanced portfolio and plans for delivering additional meaningful...

Oct 28, 2013, 09:09 ET

Boston Scientific Receives CE Mark For Lotus™ Valve System

 Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Lotus™ Valve System, the company's advanced transcatheter aortic...

Oct 24, 2013, 07:20 ET

Boston Scientific Announces Transition Plan For New Chief Financial Officer

Boston Scientific Corporation (NYSE: BSX) has initiated a transition plan for its new chief financial officer. Noting a desire to pursue...

Oct 24, 2013, 07:00 ET

Boston Scientific Announces Results For Third Quarter Ended September 30, 2013

 Boston Scientific Corporation (NYSE: BSX) generated sales of $1.735 billion and adjusted earnings per share of $0.17 for the third quarter...

Oct 23, 2013, 16:30 ET

Boston Scientific Alair® Bronchial Thermoplasty System Approved In China

Boston Scientific Corporation (NYSE: BSX) has received China Food and Drug Administration approval for the Alair® Bronchial Thermoplasty...

Oct 23, 2013, 08:15 ET

Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology

The Boston Scientific Corporation (NYSE: BSX) S-ICD® System has received the Prix Galien USA 2013 Award for Best Medical Technology.  The...

Oct 10, 2013, 09:30 ET

Boston Scientific To Webcast Conference Call Discussing Third Quarter 2013 Financial Results On October 24

 Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September...

Oct 09, 2013, 20:17 ET

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

 Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has...

Oct 08, 2013, 17:45 ET

New Data Published In EP EuroPace Journal Highlights Differences In CRT-ICD Battery Longevity Across Manufacturers

 An independent and first-of-its-kind study from the University of Pittsburgh Medical Center, published online this week in EP EuroPace, shows...

Oct 08, 2013, 15:01 ET

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

The Boston Scientific (NYSE: BSX) OffRoad™ Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of...

Sep 26, 2013, 09:23 ET

Boston Scientific verkündet positive 6-Monats-Daten aus der klinischen Studie zum Lotus™ -Klappensystem

REPRISE-II-Daten wurden im Rahmen des PCR London Valves Course zum "Best Abstract 2013" gekürt Boston Scientific Corporation (NYSE:BSX) hat...

Sep 24, 2013, 04:16 ET

Boston Scientific comunica i risultati positivi a sei mesi dello studio clinico sulla valvola Lotus™

I dati di REPRISE II premiati con il Miglior Abstract 2013 al PCR London Valves Course La Boston Scientific Corporation (NYSE: BSX) ha comunicato...

Sep 24, 2013, 04:14 ET

Boston Scientific presente les resultats favorables de l'essai clinique mene sur la valve Lotus™ a six mois de suivi

La présentation des données de REPRISE II a obtenu la distinction « Meilleur Abstract 2013 » au Congrès...

Sep 17, 2013, 06:00 ET

Boston Scientific Opens Institute For Advancing Science, Innovation Center In Shanghai

 Reinforcing its ongoing commitment to leadership in the global medical technology market, Boston Scientific Corporation (NYSE: BSX) today...

Sep 17, 2013, 04:30 ET

Boston Scientific Reports Favorable Six-Month Results From Lotus™ Valve System Clinical Trial

Boston Scientific Corporation (NYSE: BSX) reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical...

Sep 17, 2013, 04:00 ET

OrbusNeich, Boston Scientific Settle Patent Litigation

OrbusNeich Medical Inc. and Boston Scientific Corporation (NYSE: BSX) have settled all stent-related litigation between the companies.  The...

Sep 12, 2013, 17:00 ET

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

 In a significant milestone toward obtaining additional key regulatory approvals for the SYNERGY™ Stent System, Boston Scientific...